Company
Headquarters: Lund, Sweden
Employees: 92
kr17.67 Billion
SEK as of July 1, 2024
US$1.66 Billion
Company | Market Cap (USD) |
---|---|
Intuitive | $154.23 B |
EssilorLuxottica SA | $98.99 B |
Becton, Dickinson and Company | $65.82 B |
Alcon Inc. | $43.72 B |
HOYA Corp | $42.76 B |
Company | Market Cap (USD) |
---|---|
Lilly | $808.65 B |
Novo Nordisk | $622.07 B |
UnitedHealth Group | $450.89 B |
Johnson & Johnson | $350.63 B |
Merck | $318.75 B |
Bonesupport Holding AB (publ), an orthobiologics company, develops and commercializes injectable bioceramic bone graft substitutes for the treatment of bone voids in Europe, North America, and internationally. The company provides CERAMENT Bone Void Filler, an injectable, moldable, and drillable synthetic bone void filler that includes hydroxyapatite, calcium sulfate, and the radio-contrast agent iohexol; CERAMENT G, a gentamicin injectable ceramic bone graft substitute; and CERAMENT V, a vancomycin injectable synthetic bone void filler. It also develops preclinical product candidates to promote bone regrowth focusing on trauma, revision arthroplasty, chronic osteomyelitis, revision artroplasty, and oncology, as well as bone and foot infections due to diabetes. The company was founded in 1999 and is headquartered in Lund, Sweden.
Top 1-year algo backtest: +265.99%
$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Bonesupport Holding AB has the following listings and related stock indices.
Stock: OMX: BONEX wb_incandescent
Stock: FSX: 2B4 wb_incandescent
Stock: OTC: BOEUF wb_incandescent